Trials / Unknown
UnknownNCT00935675
Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer Treatment
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the effectiveness of escitalopram on depressive symptoms after 3 months in patients with head and neck squamous cell carcinomas (oral cavity, larynx, oropharynx and hypopharynx) and with an HADS total score \> 11
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Escitalopram | Escitalopram 10 mg once a day |
Timeline
- First posted
- 2009-07-09
- Last updated
- 2009-09-02
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00935675. Inclusion in this directory is not an endorsement.